IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $109 | -100.0% | 3,073 | -84.9% | 0.00% | -100.0% |
Q3 2022 | $898,000 | +739.3% | 20,390 | +757.4% | 0.01% | – |
Q1 2021 | $107,000 | -94.5% | 2,378 | -93.1% | 0.00% | -100.0% |
Q4 2020 | $1,946,000 | +63.0% | 34,404 | +36.8% | 0.01% | +60.0% |
Q3 2020 | $1,194,000 | -65.4% | 25,157 | -57.0% | 0.01% | -66.7% |
Q2 2020 | $3,452,000 | +6538.5% | 58,523 | +5205.8% | 0.02% | – |
Q1 2020 | $52,000 | -71.4% | 1,103 | -63.4% | 0.00% | -100.0% |
Q4 2019 | $182,000 | +193.5% | 3,010 | +212.6% | 0.00% | – |
Q2 2019 | $62,000 | -18.4% | 963 | +2.6% | 0.00% | – |
Q1 2019 | $76,000 | -63.3% | 939 | -75.5% | 0.00% | -100.0% |
Q4 2018 | $207,000 | +2487.5% | 3,828 | +2322.8% | 0.00% | – |
Q3 2018 | $8,000 | +14.3% | 158 | 0.0% | 0.00% | – |
Q2 2018 | $7,000 | +250.0% | 158 | +229.2% | 0.00% | – |
Q1 2018 | $2,000 | -98.6% | 48 | -98.3% | 0.00% | -100.0% |
Q4 2017 | $143,000 | -16.4% | 2,829 | -16.3% | 0.00% | 0.0% |
Q3 2017 | $171,000 | +2750.0% | 3,380 | +2263.6% | 0.00% | – |
Q1 2017 | $6,000 | -25.0% | 143 | +6.7% | 0.00% | – |
Q4 2015 | $8,000 | – | 134 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |